The yeast Saccharomyces cerevisiae has been used to study the function of components of the actin cytoskeleton in vivo, mainly because It is easy to derive and characterize mutations affecting these proteins. In contrast, biochemical studies have generally used proteins derived from higher eukaryotes. We have devised a simple procedure to prepare, in high yield, homogeneous native actin from wild-type and act] mutant yeast. Using intensified video fluorescence microscopy, we found that actin filaments polymerized from these preparations exhibit ATP-dependent sliding movement over surfaces coated with rabbit skeletal muscle myosin. The rates of sliding movement of the wild-type and mutant yeast actins were each about half that of rabbit skeletal muscle actin under similar conditions. We conclude that over the large evolutionary distance between yeast and mammals there has been si iant conservation of actin function, specifically the ability to be moved by interaction with myosin.
The interaction of the ubiquitous eukaryotic proteins actin and myosin couples the hydrolysis of ATP to force production, driving muscle contraction and many other types of cell motility. After nearly 50 years of intense biochemical and structural analysis of actin-myosin interaction, the mechanisms of both chemomechanical coupling and regulation of actomyosin activity remain obscure. To enhance structurefunction studies of proteins purified from mammalian muscle tissues, powerful biochemical techniques have been developed that provide true functional assays for actin-myosin interaction. The sliding movement of actin filaments over myosin-coated surfaces can be directly observed by fluorescence microscopy (1), reconstituting motility in a geometry where quantitative measurement of rates of movement (2) and magnitude of forces (3) can be made with purified proteins. However, lack of access to mutational analysis in studies with muscle proteins limits further progress. Bacterial expression of the cloned muscle actin and myosin genes has not yielded biochemical quantities of stable, soluble proteins. Although expression of modified muscle protein genes in both muscle and nonmuscle eukaryotic cells (4, 5) has been reported, no system has been established that offers both in vivo analysis of phenotypes and in vitro analysis of purified proteins.
A potentially more powerful approach is provided by analysis ofaltered forms ofthe nonmuscle actins and myosins of single-celled organisms expressed in their natural environments, such as is possible in Dictyostelium discoideum (6, 7) and Saccharomyces cerevisiae (8) . The wild-type forms of these myosins and actins have been found by many criteria to be structurally and functionally interchangeable with their cognate muscle proteins. Studies in either slime mold or yeast have the potential to permit both analysis of in vivo effects of site-directed mutations and ready purification ofthe modified proteins, potentiating in vitro analysis. However, the welldeveloped classical and molecular genetic approaches available with yeast facilitate the identification of sequences mediating functional interactions between proteins.
In Saccharomyces, conventional actin is expressed from a single essential gene (9) , ACTI, that encodes a 374-amino acid (42-kDa) sequence 87% identical to rabbit skeletal muscle actin (10, 11) . Localization of actin in growing yeast to the bud neck and in cables pointing into the nascent bud (12, 13) suggest a role in myosin-based contraction and/or transport. Several myosin-related genes have been identified, including MYC1, the disruption of which results in a cell-division defect in the resulting mutant strain (14) , and MY02, an unconventional myosin required for proper secretory function (15) . Purified yeast and muscle actins have similar biochemical properties. Yeast actin polymerizes to form stable filaments in high-ionic-strength buffer but remains monomeric at low ionic strength. Its polymerization is inhibited by DNase I and cytochalasins and promoted by phalloidin (16) .
The stable and specific binding of monomeric actin to pancreatic DNase I that results in inhibition of DNase activity (17) (22) of the method of Pardee and Spudich (23) . Myosin was isolated from rabbit back muscle (24) . Chymotryptic myosin subfragment 1 (CT-Si) (25) and papain/Mg2e subfragment 1 (P-Mg.Sl) (2) For binding to the rabbit actin-phalloidin complex, 0-2 p.M actin was used, while for binding to yeast actin, 0-7.9 p.M actin was used. Reaction mixtures were incubated 60 min on ice before centrifugation at 4°C for 10 min at 100,000 rpm. The K+-EDTA ATPase activity remaining in the supernatant was determined.
ATPase Assays. The K+-EDTA ATPase activity of CT-Si was measured in K-ATPase buffer (25 mM imidazole/HCl, pH 7.4/0.6 M KCl/25 mM EDTA/1 mM ATP/1 mM DTT) at 30°C. Actin activation of P-Mg.S1 ATPase was measured in Mg-ATPase buffer (25 mM imidazole/HCl, pH 7.4/25 mM KCl/4 mM MgCl2/1 mM EGTA/1 mM DTT) at 300C with 1 mM ATP, 0.05% BSA, and 0-20 pM yeast or rabbit skeletal muscle actin. For rabbit actin, 0.75 pg of P-Mg.S1 was used in each reaction. For yeast actin, 6 pg of P-Mg.S1 was used.
Release of the y_[32P]phosphate from ATP was measured by precipitation of phosphomolybdate (32) .
Motility Assays. Motility was assayed essentially as described (22) , in a modified motility assay buffer (10 mM imidazole/HCl, pH 7.4/4 mM MgCl2/1 mM EGTA/2 mM DTT). In brief, P-Mg.S1, diluted in motility assay buffer, was applied to nitrocellulose-coated coverslips in a flow cell and allowed to bind. Excess P-Mg.S1 was eluted with buffer containing 0.05% BSA. Tetramethylrhodamine phalloidin (Me4RP; Molecular Probes)-labeled yeast or rabbit skeletal muscle actin filaments were diluted to 10 nM monomer in BSA-containing buffer and allowed to bind to the P-Mg.S1-coated surface. Free actin filaments were washed away with BSA-containing buffer with an enzymatic oxygen scavenging system (3) and then the same buffer with 2 mM ATP was introduced into the flow cell. The flow cell was equilibrated to 300C on the microscope stage. Sliding movement of actin filaments was observed by intensified video epifluorescence microscopy (1) and recorded on video tape. The sliding speed of actin filaments was measured from the video record with a video tracking program (33) .
RESULTS

Preparation of Yeast Ceil
Extract. An actin-rich crude cell extract was prepared by lysis in a low-ionic-strength buffer. Frozen yeast suspension (50 g of DBY877 "sleet") was melted in cool 10 mM imidazole/HCl (pH 7.4), and the cells were centrifuged to a pellet. The pellet was resuspended to a 50%o (wt/vol) cell suspension in ice-cold lysis buffer [10 mM imidazole/HCl, pH 7.4/0.5 mM CaCl2/0.5 mM ATP with 1:200 protease inhibitor mixture (leupeptin, 1.6 mg/ml; pepstatin, 0.8 mg/ml; chymostatin, 0.2 mg/ml; aprotinin, 0.2 mg/ml; soybean trypsin inhibitor, 0.8 mg/ml; suspension in ethanol and water, stored frozen at -20°C)]. Glass beads (1-mm diameter, 50 ml) were washed with lysis buffer and cooled to 0WC. The cell slurry and glass beads were transferred to a glass-bead disruption device (Biospec Products, Bartlesville, OK; 75-ml cup), the chamber was topped off with lysis buffer, and 0.2 M phenylmethylsulfonyl fluoride in ethanol was added to 1 mM final concentration. The chamber was jacketed with an ice/salt/water bath (-5°C). The cells were disrupted with 30 cycles of 30-sec agitation and 90-sec cooling interval, resulting in >99% lysed cells as judged by phase-contrast microscopy. The lysate was cool (<40C) when recovered from the disruptor. (Warming during lysis resulted in markedly reduced yields.) The slurry of cell lysate and glass beads was filtered through nylon cloth and the retained beads were washed with lysis buffer. The extract was then centrifuged 60 min at 50,000 rpm in a Ti7O rotor (Beckman) at 4E. The high-speed supernatant (80 ml) contained 655 mg of protein and 2200 units of DNase I inhibition activity.
DNase I Affinity Chromatography of Crude Extract. DNase I affinity chromatography was found to give an impressive single-step purification of the crude extract. The Affi-Gel DNase I affinity column (2.5 x 3 cm) and the Sephadex G-25 (Pharmacia LKB) column (2.5 x 40 cm) were equilibrated with DNase column buffer at 4O(. Flow was maintained at 0.5 ml/min by a peristaltic pump. The high-speed supernatant was diluted with 80 ml of column buffer and applied to the DNase I column. Unbound protein was eluted with several volumes of column buffer. Assay of the flowthrough showed that all DNase-inhibiting activity had been retained. Following the method of Zechel (20) , the column was washed with 20 ml each of 10%6 formamide in column buffer, 10% formamide/0.2 M NH4Cl in column buffer, and then column buffer alone. The outlet of the DNase column was then connected to the inlet of the G-25 column and the DNase column was eluted with 20 ml of 50%6 formamide in column buffer and washed with 20 ml of column buffer. The DNase column was bypassed and the elution of the G-25 column continued. Protein-containing fractions eluted from the G-25 column were pooled (Fig. 1) . The DNase/G-25 column pool (22.5 ml) contained 2.9 mg of protein and 3400 units. This single step resulted in apparently complete recovery of the loaded actin and a purification of >200-fold.
Ion-Exchange Chromatography. Purification and concentration of the DNase I column pool was performed by medium-pressure anion-exchange chromatography. A DEAE 650M column (0.6 x 12 cm) was equilibrated with DNase column buffer and the DNase I affinity column/G-25 pool was loaded at 1 ml/min and washed at 1 ml/min with column buffer. No protein was detected in the flowthrough.
Elution with a 15-ml linear gradient of 0-400 mM KCl in column buffer gave a single peak of protein at 200 mM KCl ( Fig. 1 b and c) . At this point, the total purification was calculated to be >200-fold with a yield approaching 100% and a net concentration of nearly 100-fold (Table 1) .
DNase/DEAE-Purified Rabbit Skeletal Muscle Actin. To compare conventionally prepared actin with that prepared by the described method, we performed DNase and DEAE chromatography on rabbit skeletal muscle actin. Rabbit skeletal muscle actin (22) was dialyzed against DNase column buffer to prepare a solution of monomeric actin. This was applied to the DNase I affinity column and eluted as described above. The DNase/G-25 pool was applied to the DEAE column and eluted as described above. The fractions that eluted near 200 mM KCl were viscous. The repurified actin was "cycled" by sequential depolymerization and repolymerization (23) and stored on ice. DNase/DEAEpurified skeletal muscle actin was indistinguishable from conventionally purified actin in its ability to activate myosin P-Mg.Sl Mg2+-ATPase and in its rate of sliding over P-Mg.Sl-coated surfaces (data not shown). This actin was remarkably stable, maintaining its viscosity when stored on ice for many months.
Polymerization of DNase/DEAE-Purifled Yeast Actin. Even brief contact ofactin with formamide may result in loss of polymerizability due to denaturation (20) . However, yeast actin purified by DNase affinity and DEAE chromatography was found to be assembly-competent. The DEAE pool was dialyzed against depolymerization buffer (2.5 mM imidazole/ HCI, pH 7.4/0.5 mM CaCI2/0.5 mM ATP/0.5 mM DTT) overnight at 40C, recovered from dialysis (DEAE pool, 1 To remove any nonpolymerizable species, actin was "cycled" by polymerization/depolymerization. A 1.0-ml aliquot of the polymerized DEAE pool (0.93 mg/ml) was centrifuged 30 min at 100,000 rpm in a TL100.3 rotor and the supernatant (1.0 ml, 0.17 mg/ml) was drawn off. The pellet was washed and soaked in depolymerization buffer, resuspended to 0.2 ml, dialyzed overnight at 40C against this buffer, and then recentrifuged. To polymerize the actin supernatant, 1/19th volume of 20x polymerization buffer was added (final volume, 0.21 ml; final protein concentration, 4.3 mg/ml). The yield of cycled actin was 95%.
Binding of Yeast Actin to Myosin Subfragment 1 and Activation of ATPase. Consistent with the results of Greer and Schekman (16), we found that yeast actin is a significantly weaker activator of rabbit skeletal muscle myosin Mg2+-ATPase than skeletal muscle actin, using activation of P-Mg.S1 Mg2+-ATPase (Fig. 2 Upper) . We examined the basis for this difference by measuring the relative binding affinity of CT-S1 for the two actins. A binding assay performed in the absence of ATP revealed a remarkably lower apparent "rigor" affinity of CT-Si for yeast actin than for skeletal muscle actin (Fig. 2 Lower). CT-S1 formed a stoichiometric complex with skeletal muscle actin filaments [stabilized with a molar excess of phalloidin (Calbiochem)] even at 0.2 uM actin monomer, whereas binding to yeast actin was insignificant below 1 pM actin. (Upper) Actin-stimulated Mg2+-ATPase activity of rabbit skeletal muscle P-Mg.S1 at a series of yeast and skeletal muscle actin concentrations. (Lower) Binding of CT-S1 to yeast actin or skeletal muscle actin-phalloidin complex in the absence of ATP. Bound CT-S1 was measured from depletion of actin-independent myosin ATPase after centrifugation to pellet actin filaments.
Fluorescent Actin Filaments. To fluorescently label the purified yeast actin filaments, Me4RP was mixed at a slight molar excess with actin (1 uM monomer) in motility assay buffer and incubated at 0°C (22) . When the labeled actin filaments were diluted to =10 nM actin monomer, individual actin filaments could be imaged by rhodamine fluorescence in intensified video epifluorescence microscopy. The Me4RP-labeled actin filaments were uniformly bright and varied between <1 pM and >10 um in length. In comparison to similarly labeled skeletal muscle actin filaments, yeast actin appeared to be less rigid, with filaments often demonstrating sharp bends and tightly wound loops without fracture. The stability of yeast actin filaments under fluorescence illumination with respect to photobleaching and.filament fragmentation was similar to that of Me4RP-labeled skeletal muscle actin. However, independent of illumination, when the labeled filaments were diluted into buffer, their fluorescence gradually decreased over a period of minutes, suggesting a markedly lower affinity for phalloidin than that of skeletal muscle actin. The rate of loss offluorescence from yeast actin filaments increased with increasing temperature.
Actin Sliding Movement over Myosin-Coated Surfaces. In the in vitro motility assay, Me4RP-labeled yeast actin filaments moved on skeletal muscle myosin-coated surfaces in an ATP-dependent manner. When P-Mg.S1 was applied to a nitrocellulose surface and Me4RP-labeled yeast actin was diluted and introduced into the flow cell, actin filaments bound to the myosin-coated surface along their lengths in a stable rigor association. When 2 mM ATP was infused, actin filaments immediately began sliding over the surface.
The movement of yeast actin filaments over P-Mg.S1-coated surfaces was distinct from that of skeletal muscle actin filaments. At 22°C, only a fraction of the yeast actin filaments that had bound to the surface were observed to undergo sliding movement when ATP was infused, and the moving filaments exhibited intermittent sliding interrupted by periods of binding to the surface. Such behavior is characteristic of the movement of skeletal muscle actin only at lower temperatures (<15°C) or in very low-ionic-strength buffers. At 30°C, though nearly all yeast actin filaments exhibited smooth sliding movement, the sliding speed of yeast actin was significantly slower than that of skeletal muscle actin.
While DNase/DEAE-purified skeletal muscle actin moved over P-Mg.S1 at 0.95 ± 0. 10 (34) found that proteolytic cleavage of skeletal muscle actin within a boundary between the N terminus and the actin "core" strongly affects actin sliding movement over skeletal muscle myosin, producing a form of actin with motility properties very similar to those of yeast actin. Sutoh et al. (7) found that replacing N-terminal aspartates of Dictyostelium actin with histidine residues resulted in a similar change in the motility properties of this actin. These and other data suggest that the close association of the actin N terminus with a site at the junction between two subdomains in the myosin head reflects an important functional interaction. As suggested for cleaved actin (34) , it may be that binding of yeast actin to muscle myosin is neither stable nor stiff enough to transmit a mechanical impulse through the actin-myosin junction, uncoupling the system so that ATP hydrolysis becomes mechanically unproductive.
Our results suggest that specific models for the structural basis of both functional conservation and divergence between yeast actin and other actins can be tested directly. 
